1933 Industries Inc

Healthcare CA TGIF

0.005CAD
0.00(0%)

Last update at 2026-06-24T17:37:00Z

Day Range

0.0050.005

LowHigh

52 Week Range

0.0050.02

LowHigh

Fundamentals

Previous Close 0.005
Market Cap5.21M
Volume5150
P/E Ratio-
Dividend Yield-%
EBITDA0.19M
Revenue TTM16.95M
Revenue Per Share TTM0.03
Gross Profit TTM 2.22M
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2025-07-31	2024-07-31	2023-07-31	2022-07-31	2021-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-07-31	2024-07-31	2023-07-31	2022-07-31	2021-07-31
Income before tax	0.03M	-2.25408M	-14.07177M	-17.51667M	-5.80542M
Minority interest	0.15M	-0.18830M	0.59M	0.26M	-0.18299M
Net income	-0.21704M	-1.14200M	-13.36392M	-17.80692M	-6.47042M
Selling general administrative	1.91M	3.06M	4.34M	7.21M	7.94M
Selling and marketing expenses	-	-	-	-	-
Gross profit	5.16M	2.94M	-1.36675M	2.69M	4.82M
Reconciled depreciation	0.30M	2.08M	1.60M	1.92M	0.99M
Ebit	-	-	-	-5.01791M	-3.62048M
Ebitda	-	-	-	-13.83386M	-2.70541M
Depreciation and amortization	-	-	-	-	-
Non operating income net other	-	-	-	-	-
Operating income	0.68M	-2.31635M	-9.46577M	-5.01791M	-3.62048M
Other operating expenses	-	-	-	-	-
Interest expense	0.67M	0.49M	1.83M	1.76M	2.11M
Tax provision	0.10M	-1.63000M	0.52M	0.55M	0.48M
Interest income	-	0.00000M	0.00000M	0.02M	0.00000M
Net interest income	-0.67044M	-0.48862M	-1.83070M	-1.74308M	-2.10671M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	-	0.55M	0.48M
Total revenue	17.45M	19.35M	16.88M	12.54M	11.98M
Total operating expenses	16.76M	21.67M	26.35M	17.56M	15.60M
Cost of revenue	12.28M	16.41M	18.25M	9.85M	7.16M
Total other income expense net	0.01M	0.55M	-2.77530M	-10.75569M	-0.07824M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-0.07137M	-0.62409M	-14.58730M	-18.06567M	-6.28742M
Net income applicable to common shares	-	-	-	-17.80692M	-6.46792M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2025-07-31	2024-07-31	2023-07-31	2022-07-31	2021-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-07-31	2024-07-31	2023-07-31	2022-07-31	2021-07-31
Total assets	16.80M	16.87M	18.02M	29.01M	45.35M
Intangible assets	-	-	-	-	-
Earning assets	-	-	-	-	-
Other current assets	-	-	-	3.28M	0.08M
Total liab	21.40M	21.70M	23.28M	21.49M	20.12M
Total stockholder equity	-4.59814M	-3.53422M	-3.69294M	8.52M	25.99M
Deferred long term liab	-	-	-	-	-
Other current liab	-	-	-	1.05M	0.87M
Common stock	-	-	-	81.86M	81.82M
Capital stock	83.89M	83.86M	82.39M	81.86M	81.82M
Retained earnings	-98.75590M	-97.39930M	-95.82012M	-82.45620M	-64.64928M
Other liab	-	-	-	-	-
Good will	-	-	0.00000M	4.49M	15.53M
Other assets	-	-	-	-	-
Cash	0.55M	0.45M	1.09M	0.36M	4.41M
Cash and equivalents	-	-	-	-	-
Total current liabilities	7.67M	5.42M	10.71M	8.67M	2.71M
Current deferred revenue	-	-	-	-	-
Net debt	2.90M	2.47M	3.37M	4.21M	-
Short term debt	-	-	-	-	-
Short long term debt	3.44M	0.05M	4.44M	4.57M	-
Short long term debt total	-	-	-	-	-
Other stockholder equity	-	-	-	9.12M	8.82M
Property plant equipment	-	-	-	12.17M	18.68M
Total current assets	6.42M	5.98M	6.47M	12.35M	11.15M
Long term investments	-	-	-	-	-
Net tangible assets	-	-	-	4.03M	10.47M
Short term investments	-	-	-	-	-
Net receivables	2.03M	2.01M	2.23M	1.34M	0.80M
Long term debt	-	2.87M	0.02M	-	4.23M
Inventory	3.53M	3.15M	2.61M	7.17M	5.07M
Accounts payable	3.00M	3.94M	3.39M	2.76M	1.38M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	-	-
Deferred long term asset charges	-	-	-	-	-
Non current assets total	10.38M	10.88M	11.55M	16.66M	34.20M
Capital lease obligations	14.16M	13.85M	13.11M	13.11M	13.64M
Long term debt total	-	-	-	-	-

Breakdown	2025-07-31	2024-07-31	2023-07-31	2022-07-31	2021-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-07-31	2024-07-31	2023-07-31	2022-07-31	2021-07-31
Investments	-	-0.89078M	2.41M	0.00158M	-0.45636M
Change to liabilities	-	-	-	1.31M	0.05M
Total cashflows from investing activities	-	-	-	0.00158M	-0.45636M
Net borrowings	-1.57909M	-1.46125M	-0.30094M	-0.40331M	-0.10984M
Total cash from financing activities	-1.57909M	-1.46125M	-0.30094M	1.53M	6.06M
Change to operating activities	-	-	-	0.37M	0.06M
Net income	-0.21704M	-1.14200M	-13.36392M	-17.80692M	-6.47042M
Change in cash	0.09M	-0.68606M	0.73M	-4.04258M	1.64M
Begin period cash flow	0.45M	1.09M	0.36M	4.41M	2.76M
End period cash flow	0.55M	0.45M	1.09M	0.36M	4.41M
Total cash from operating activities	1.84M	1.65M	-1.52787M	-5.08539M	-4.66580M
Issuance of capital stock	-	-	-	0.00000M	6.66M
Depreciation	0.30M	2.08M	1.60M	0.50M	0.50M
Other cashflows from investing activities	-	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	0.31M	-0.54767M	3.95M	-3.48009M	-0.99381M
Change to account receivables	-	-	-	-0.34063M	-0.03225M
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	-	-	-	1.94M	-0.49264M
Change to netincome	-	-	-	13.80M	1.73M
Capital expenditures	0.17M	0.89M	0.80M	0.01M	0.46M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.03M	-1.00683M	4.64M	-1.57657M	-0.42673M
Stock based compensation	0.00462M	0.03M	0.18M	0.01M	1.03M
Other non cash items	1.59M	1.65M	1.61M	0.84M	-0.42689M
Free cash flow	1.67M	0.76M	-2.32986M	-5.10030M	-5.12216M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
TGIF 1933 Industries Inc	- -%	0.005	-	-	0.31	1.36	1.19	25.43
GTII Green Thumb Industries Inc	-0.18 1.77%	10.00	14.70	34.84	1.91	0.86	1.61	3.95
CL Cresco Labs Inc	-0.02 1.80%	1.09	-	105.26	0.70	0.99	1.32	42.44
JUSH Jushi Holdings Inc	0.01 1.61%	0.63	-	17.86	0.52	0.69	1.41	9.56
GRIN Grown Rogue International Inc	-0.02 3.33%	0.58	23.50	-	3.62	4.10	3.13	11.19

Reports Covered

View All

Profile

1933 Industries Inc., together with its subsidiaries, engages in the cultivation, extraction, and production of cannabis products in the United States. It operates through AMA and Infused MFG segments. The company offers craft-style cannabis, branded flower, infused pre-rolls, full spectrum oils, distillates, and blends of terpenes; vaporizer products and boutique concentrate, such as shatter, crumble, batter, sugar wax, diamonds, and cured and live resins under the AMA and Level X brands. It also provides cannabidiol, and cannabinol infused products. The company sells its products through licensed dispensaries, as well as direct to consumers via e-commerce at cannahemp.com. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada.

1933 Industries Inc

1055 West Hastings Street, Vancouver, BC, Canada, V6E 2E9

604 728 4407
https://www.1933industries.com
Employees : 85

Key Executives

Name	Title	Year Born
Mr. Brian Farrell B.Comm, CA	Interim CEO & Interim Chairman of the Board	NA
Ms. Ester Vigil	President	NA
Mr. Jeremy Fong	Chief Financial Officer	NA
Ms. Kathy Estochin	Vice President of Finance & Administration	NA
Ms. Alexia Helgason	Vice President of Investor Relations	NA
Ms. Marion McGrath	Company Secretary	1961
Mr. Brent Hilton	Controller	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.